📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential. (2021)

First Author: Gorman E

Attributed to: A GMP cell therapy facility to test cell based therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/17476348.2021.1848555

PubMed Identifier: 33172313

Publication URI: http://europepmc.org/abstract/MED/33172313

Type: Journal Article/Review

Volume: 15

Parent Publication: Expert review of respiratory medicine

Issue: 3

ISSN: 1747-6348